Aripiprazole Treatment for Methamphetamine Dependence Among High-Risk MSM - Related Studies

Aripiprazole Treatment for Methamphetamine Dependence Among High-Risk MSM

This study is currently recruiting participants.

Study NCT00497055. Last updated on August 6, 2008. Information provided by National Institute on Drug Abuse (NIDA)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Substance Abuse
		HIV Infections

2	Additional conditions recognized in this trial
		Acquired Immunodeficiency Syndrome
		Infection
		Substance-Related Disorders

3	More general conditions related to this trial
		Disorders of Environmental Origin
		Immune System Diseases
		Immunologic Deficiency Syndromes
		Lentivirus Infections
		Mental Disorders
		Retroviridae Infections
		RNA Virus Infections
		Sexually Transmitted Diseases
		Sexually Transmitted Diseases, Viral
		Slow Virus Diseases
		Virus Diseases

4	Interventions listed in this trial
		aripiprazole

5	Additional drug interventions recognized in this trial
		Methamphetamine

6	More general drug interventions related to this trial
		Adrenergic Agents
		Adrenergic Uptake Inhibitors
		Antipsychotic Agents
		Autonomic Agents
		Central Nervous System Agents
		Central Nervous System Depressants
		Central Nervous System Stimulants
		Dopamine Agents
		Dopamine Uptake Inhibitors
		Molecular Mechanisms of Pharmacological Action
		Neurotransmitter Agents
		Neurotransmitter Uptake Inhibitors
		Peripheral Nervous System Agents
		Pharmacologic Actions
		Physiological Effects of Drugs
		Psychotropic Drugs
		Sympathomimetics
		Therapeutic Uses
		Tranquilizing Agents

7	Sponsors listed in this trial
		National Institute on Drug Abuse (NIDA)